SAMSUNG PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 001360 for the last quarter is 10.58 B KRW, and it's 13.07% lower compared to the previous quarter. The net income of Q2 24 is -10.28 B KRW.